SCHEMBL28885252

SCHEMBL28885252

CC(C)(C)OC(=O)N1CCC(=CN2CCOCC2)CC1

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 1/20 0.62
▸ SMN1; SMN2 Q16637 1/20 0.62
▸ RECQL P46063 1/20 0.51
▸ GRM5 P41594 1/20 0.42
▸ GPR119 Q8TDV5 3/20 0.42
▸ ESR2 Q92731 1/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ NR1H2 P55055 1/20 0.39
▸ PIK3CA P42336 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20139339 0.88 HPGD (0.48) USP2SMN1; SMN2RECQLGRM5GPR119
SCHEMBL20645659 0.81 USP2 (0.46) USP2SMN1; SMN2GRM5GPR119RAB9A
SCHEMBL344191 0.79 SMN1; SMN2 (0.96) USP2SMN1; SMN2RECQLGPR119RAB9A
SCHEMBL20448044 0.78 SMN1; SMN2 (1.00) USP2SMN1; SMN2RECQLGPR119RAB9A
SCHEMBL24673913 0.77 USP2 (0.51) USP2SMN1; SMN2RECQLGRM5GPR119
SCHEMBL10253506 0.77 USP2 (0.51) USP2SMN1; SMN2RECQLGRM5GPR119
SCHEMBL30897992 0.75 USP2 (0.50) USP2SMN1; SMN2RECQLGRM5GPR119
SCHEMBL513246 0.75 USP2 (0.50) USP2SMN1; SMN2RECQLGRM5GPR119
Acetic Acid SCHEMBL29118271 0.75 SMN1; SMN2 (0.86) USP2SMN1; SMN2RECQLGPR119RAB9A
SCHEMBL2948300 0.74 USP2 (0.49) USP2SMN1; SMN2RECQLGRM5GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108440507-B Compound as apoptosis protein inhibitor and application thereof 南京圣和药物研发有限公司 2022-10-18 — — CN disclosed
Send feedback